![](https://www.amyltx.com/wp-content/uploads/2021/04/Amyl-Icons-2-01-1.png)
About Amyl Therapeutics
A preclinical-stage biotechnology company pioneering a breakthrough approach to treat rare and severe peripheral protein misfolding diseases and neurodegenerative diseases.
![](https://www.amyltx.com/wp-content/uploads/2021/04/Amyl-Icons-2-02-1.png)
Our Science
Our scientists work on a proprietary technology, that is able to bind to various types of amyloid fibrils and induce their clearance.
![](https://www.amyltx.com/wp-content/uploads/2021/04/Amyl-Icons-2-03-1.png)
Our Programmes
Our therapies are designed to target multiple misfolded proteins implicated in both peripheral diseases involving systemic protein misfolding pathologies and neurodegenerative diseases.